WallStreetZenWallStreetZen

NASDAQ: JSPR
Jasper Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Jasper Therapeutics earnings were -$63.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest JSPR earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$18.6M, up 27.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, JSPR reported annual earnings of -$64.5M, with 71.1% growth.

JSPR earnings history

Current Revenue
$0.0
Current Earnings
-$63.5M
Current Profit Margin
0%

JSPR Return on Equity

Current Company
-67.6%
Current Industry
20.1%
Current Market
36.1%
JSPR's Return on Equity (-67.6%)... subscribe to Premium to read more.
High Return on Equity Performance

JSPR Return on Assets

Current Company
-58.5%
Current Industry
1.4%
JSPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when JSPR announces earnings.

JSPR Return on Capital Employed

Current Company
-73.06%
Current Industry
14.4%
JSPR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JSPR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
JSPR-$61.65M-$63.53MN/A-$4.72
ABSI-$83.27M-$97.67MN/A-$0.93
DSGN-$47.18M-$47.78MN/A-$0.85
SAGE-$336.28M-$337.59MN/A-$5.57
NGNE-$65.52M-$71.13MN/A$31.92
View Top Biotech Stocks

Jasper Therapeutics Earnings Reports & History FAQ

What were Jasper Therapeutics's earnings last quarter?

On JSPR's earnings call on Invalid Date, Jasper Therapeutics (NASDAQ: JSPR) reported Q3 2024 earnings per share (EPS) of -$1.24, up 22.5% year over year. Total JSPR earnings for the quarter were -$18.64 million. In the same quarter last year, Jasper Therapeutics's earnings per share (EPS) was -$1.60.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.

Is Jasper Therapeutics profitable or losing money?

As of the last Jasper Therapeutics earnings report, Jasper Therapeutics is currently losing money. Jasper Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$63.53 million, a 3.98% increase year over year.

What was JSPR's earnings growth in the past year?

As of Jasper Therapeutics's earnings date in Invalid Date, Jasper Therapeutics's earnings has grown year over year. JSPR earnings in the past year totalled -$63.53 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.